According to a new report Asia Pacific Vascular Graft Market, published by KBV research, the Asia Pacific Vascular Graft Market Size would witness market growth of 7.6% CAGR during the forecast period (2017 - 2023).
The Endovascular Aneurysm Repair Stent Grafts market held the largest share in the Asia Pacific Vascular Graft Market by Product in 2016, and would continue to be a dominant market till 2023. The Peripheral vascular graft market is expected to witness a CAGR of 10.6% during (2017 - 2023).
The Japan market held the largest share in the Asia Pacific Abdominal Aortic Aneurysm (AAA) Market by Country in 2016, and would continue to be a dominant market till 2023; thereby, growing at a CAGR of 2.9 % during the forecast period.
The Polytetrafluoroethylene (PTFE) market held the largest share in the Asia Pacific Vascular Graft Market by Raw Material in 2016, and would continue to be a dominant market till 2023. The Polyurethane (PU) market is expected to witness a CAGR of 9.9% during (2017 - 2023).
The Japan market dominated the Asia Pacific Vascular Graft Market by Country in 2016, and would continue to be a dominant market till 2023, growing at a CAGR of 4% during the forecast period. The India Vascular Graft Market attained a market size of $122.2 million in 2016 and it is expected to grow at a CAGR of 11.2% during 2017 -2023.
Full Report: https://www.kbvresearch.com/asia-pacific-vascular-graft-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key impacting factors of the Asia-Pacific Vascular Graft Market have been discussed in the report with the elaborated company profiles of B. Braun Melsungen AG, C. R. Bard, Inc., Cardinal Health Inc., Medtronic, Endologix Inc., Cook Medical Inc., LeMaitre Vascular, Inc., Terumo Corporation, W. L. Gore & Associates, Inc., and Getinge AB.
By Product
By Raw Material
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
Related Reports:
Unique Offerings 
